{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:57:41Z","timestamp":1793836661736,"version":"4.6.1"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jcim-2024-0443_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Cancer remains a significant global health challenge, with prostate, breast, and ovarian cancers ranking among the leading causes of morbidity and mortality. Natural products, particularly those derived from medicinal plants, have gained attention for their potential in alternative cancer therapies. The main objective of the study was an isolation and characterization of Jerantinine A, a bioactive alkaloid from\n                      <jats:italic>Tabernaemontana coronaria<\/jats:italic>\n                      , and its interactions with key protein targets involved in cancer progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0443_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Jerantinine A was isolated through column chromatography and characterized using spectroscopic techniques, including UV-visible spectroscopy, FTIR, and NMR. Molecular docking studies were performed to assess its binding affinities with six critical protein targets: PTEN and androgen receptor for prostate cancer, CXCR4 and HER2 for ovarian cancer, and CDK1 and NEK2 for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0443_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Molecular docking analyses revealed that Jerantinine A exhibits strong binding affinities with all six protein targets, suggesting its potential to inhibit cancer cell proliferation by interfering with key signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jcim-2024-0443_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings underscore the therapeutic potential of\n                      <jats:italic>T.\u00a0coronaria<\/jats:italic>\n                      , particularly through Jerantinine A, as a promising candidate for cancer treatment. By targeting pivotal proteins associated with prostate, breast, and ovarian cancers, Jerantinine A offers a foundation for further research and development as a novel anti-cancer agent.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jcim-2024-0443","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:41:28Z","timestamp":1743136888000},"page":"363-372","source":"Crossref","is-referenced-by-count":20,"title":["Exploring the anticancer potential of Jerantinine A from\n                    <i>Tabernaemontana coronaria<\/i>\n                    against prostate, breast, and ovarian cancers: a computational approach"],"prefix":"10.1515","volume":"22","author":[{"given":"Poornima","family":"Kannappan","sequence":"first","affiliation":[{"name":"Department of Biochemistry , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Kaniyur Chandrasekaran","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Vani Raju","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankari","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"},{"name":"Centre for Bioinformatics , Karpagam Academy of Higher Education , Coimbatore , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhu","family":"Dhamodharan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"},{"name":"Centre for Bioinformatics , Karpagam Academy of Higher Education , Coimbatore , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathi","family":"Muthaiyan Ahalliya","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"},{"name":"Department of Biotechnology , Karpagam Academy of Higher Education , Coimbatore , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chella Perumal","family":"Palanisamy","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research , Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS) , Thandalam, Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Raju","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research , Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS) , Thandalam, Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-1424","authenticated-orcid":false,"given":"Gopalakrishnan","family":"Velliyur Kanniappan","sequence":"additional","affiliation":[{"name":"Department of Physiology , 194347 Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS) , Thandalam, Chennai , Tamil Nadu , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"2026101405585241008_j_jcim-2024-0443_ref_001","doi-asserted-by":"crossref","unstructured":"Bray, F, Laversanne, M, Sung, H, Ferlay, J, Siegel, RL, Soerjomataram, I, et al.. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_002","doi-asserted-by":"crossref","unstructured":"Huang, J, Chan, WC, Ngai, CH, Lok, V, Zhang, L, Lucero-Prisno, DE, et al.. On behalf of NCD Global Health Research Group of Association of Pacific Rim Universities, worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. Cancers (Basel) 2022;14:2230. https:\/\/doi.org\/10.3390\/cancers14092230.","DOI":"10.3390\/cancers14092230"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_003","doi-asserted-by":"crossref","unstructured":"Raju, MV, Chandrasekaran, MK, Rajendran, MS, Kanniappan, GV, Ahalliya, RM, Dugganaboyana, GK, et al.. Deciphering the therapeutic, larvicidal, and chemical pollutant degrading properties of leaves-mediated silver nanoparticles obtained from Alpinia purpurata. BioResources 2024;19:3328\u201352. https:\/\/doi.org\/10.15376\/biores.19.2.3328-3352.","DOI":"10.15376\/biores.19.2.3328-3352"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_004","doi-asserted-by":"crossref","unstructured":"Wang, L, Lu, B, He, M, Wang, Y, Wang, Z, Du, L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health 2022;10:811044. https:\/\/doi.org\/10.3389\/fpubh.2022.811044.","DOI":"10.3389\/fpubh.2022.811044"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_005","doi-asserted-by":"crossref","unstructured":"Wilkinson, L, Gathani, T. Understanding breast cancer as a global health concern. Br J Radiol 2022;95:20211033. https:\/\/doi.org\/10.1259\/bjr.20211033.","DOI":"10.1259\/bjr.20211033"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_006","doi-asserted-by":"crossref","unstructured":"Raju, MV, Sekar, S, Chandrasekaran, MK, Rajendran, MS, Ahalliya, RM. Evaluation of the antioxidant activity of novel south Indian plant Commelina forskaolii and its prospective anticancer activity in Hep G2 cells. Indian J Nat Prod Resour 2024;15:65\u201372. https:\/\/doi.org\/10.56042\/ijnpr.v15i1.4468.","DOI":"10.56042\/ijnpr.v15i1.4468"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_007","doi-asserted-by":"crossref","unstructured":"Sabu, A, Selvaraj, J, Gayathridevi, R, Dilipan, E. In-vitro anticancer activity of Rauvolfia tetraphylla extract on MCF-7 breast cancer cell lines. Bioinformation 2023;19:43\u20137. https:\/\/doi.org\/10.6026\/97320630019043.","DOI":"10.6026\/97320630019043"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_008","doi-asserted-by":"crossref","unstructured":"Assefa, T, Tesso, H, Ramachandran, VP, Guta, L, Demissie, TB, Ombito, JO, et al.. In silico molecular docking analysis, cytotoxicity, and antibacterial activities of constituents of fruits of Cucumis dipsaceus. ACS Omega 2023;9:1945\u201355. https:\/\/doi.org\/10.1021\/acsomega.3c08866.","DOI":"10.1021\/acsomega.3c08866"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_010","doi-asserted-by":"crossref","unstructured":"Poornima, K, Krishnan, R, Aswathi, KV, Gopalakrishnan, VK. Toxicological evaluation of ethanolic extract of Tabernaemontana coronaria (L) R. Br. Asian Pacific J Tropical Dis 2012;2:S679\u201384. https:\/\/doi.org\/10.1016\/s2222-1808(12)60243-6.","DOI":"10.1016\/S2222-1808(12)60243-6"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_011","doi-asserted-by":"crossref","unstructured":"Poornima, K, Gopalakrishnan, VK. Anticancer activity of Tabernaemontana coronaria against carcinogen induced clear cell renal cell carcinoma. Chinese J Biol 2014;2014:1\u20138. https:\/\/doi.org\/10.1155\/2014\/584074.","DOI":"10.1155\/2014\/584074"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_012","doi-asserted-by":"crossref","unstructured":"Sowmya, S, Gopalakrishnan, VK, Poornima, K. Enzymatic and non-enzymatic antioxidant activity of Tabernaemontana divaricata R.Br. Against DEN and Fe-NTA induced renal damage in Wistar Albino Rats. J.\u00a0Appl. Pharm. Sci. 2015;5:033\u20137. https:\/\/doi.org\/10.7324\/japs.2015.50506.","DOI":"10.7324\/JAPS.2015.50506"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_013","doi-asserted-by":"crossref","unstructured":"Iwaloye, O, Ottu, PO, Olawale, F, Babalola, OO, Elekofehinti, OO, Kikiowo, B, et al.. Computer-aided drug design in anti-cancer drug discovery: what have we learnt and what is the way forward? Inform Med Unlocked 2023;41:101332. https:\/\/doi.org\/10.1016\/j.imu.2023.101332.","DOI":"10.1016\/j.imu.2023.101332"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_014","doi-asserted-by":"crossref","unstructured":"Luongo, F, Colonna, F, Calap\u00e0, F, Vitale, S, Fiori, ME, De Maria, R. PTEN tumor-suppressor: the dam of stemness in cancer. Cancers (Basel) 2019;11:1076. https:\/\/doi.org\/10.3390\/cancers11081076.","DOI":"10.3390\/cancers11081076"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_015","doi-asserted-by":"crossref","unstructured":"Fujita, K, Nonomura, N. Role of androgen receptor in prostate cancer: a review. World J Mens Health 2019;37:288\u201395. https:\/\/doi.org\/10.5534\/wjmh.180040.","DOI":"10.5534\/wjmh.180040"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_016","doi-asserted-by":"crossref","unstructured":"Shi, Y, Riese, DJ, Shen, J. The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer. Front Pharmacol 2020;11:574667. https:\/\/doi.org\/10.3389\/fphar.2020.574667.","DOI":"10.3389\/fphar.2020.574667"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_017","doi-asserted-by":"crossref","unstructured":"Swain, SM, Shastry, M, Hamilton, E. Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug Discov 2023;22:101\u201326. https:\/\/doi.org\/10.1038\/s41573-022-00579-0.","DOI":"10.1038\/s41573-022-00579-0"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_018","doi-asserted-by":"crossref","unstructured":"Massacci, G, Perfetto, L, Sacco, F. The Cyclin-dependent kinase 1: more than a cell cycle regulator. Br J Cancer 2023;129:1707\u201316. https:\/\/doi.org\/10.1038\/s41416-023-02468-8.","DOI":"10.1038\/s41416-023-02468-8"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_019","doi-asserted-by":"crossref","unstructured":"Kalkan, BM, Baykal, AT, Cicek, E, Acilan, C. Comprehensive proteomics analysis reveals novel NEK2-Regulated pathways and therapeutic targets in cancer. Biochem Biophys Res Commun 2024;734:150779. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150779.","DOI":"10.1016\/j.bbrc.2024.150779"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_020","doi-asserted-by":"crossref","unstructured":"Surekha, K, Nachiappan, M, Prabhu, D, Choubey, SK, Biswal, J, Jeyakanthan, J. Identification of potential inhibitors for oncogenic target of dihydroorotate dehydrogenase using in\u00a0silico approaches. J Mol Struct 2017;1127:675\u201388. https:\/\/doi.org\/10.1016\/j.molstruc.2016.08.015.","DOI":"10.1016\/j.molstruc.2016.08.015"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_021","doi-asserted-by":"crossref","unstructured":"Prabhu, D, Rajamanikandan, S, Saritha, P, Jeyakanthan, J. Evolutionary significance and functional characterization of streptomycin adenylyl transferase from Serratia marcescens. J Biomol Struct Dyn 2019;38:4418\u201331. https:\/\/doi.org\/10.1080\/07391102.2019.1682046.","DOI":"10.1080\/07391102.2019.1682046"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_022","doi-asserted-by":"crossref","unstructured":"Mohan, A, Rendine, N, Mohammed, MKS, Jeeva, A, Ji, HF, Talluri, VR. Structure-based virtual screening, in\u00a0silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 Mpro. Mol Divers 2022;26:1645\u201361. https:\/\/doi.org\/10.1007\/s11030-021-10298-0.","DOI":"10.1007\/s11030-021-10298-0"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_023","doi-asserted-by":"crossref","unstructured":"Dhamodiran, M, Chinnaperumal, K, Danish, J, Venkatesan, G, Alshiekheid, MA, Suseem, SR. Isolation, structural elucidation of bioactive compounds and their wound-healing ability, antibacterial and in silico molecular docking applications. Environ Res 2024;252:119023. https:\/\/doi.org\/10.1016\/j.envres.2024.119023.","DOI":"10.1016\/j.envres.2024.119023"},{"key":"2026101405585241008_j_jcim-2024-0443_ref_024","doi-asserted-by":"crossref","unstructured":"Kaliaperumal, K, Salendra, L, Liu, Y, Ju, Z, Sahu, SK, Elumalai, S, et al.. Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp. and in-silico computational docking approach. Front Microbiol 2023;14:1216928. https:\/\/doi.org\/10.3389\/fmicb.2023.1216928.","DOI":"10.3389\/fmicb.2023.1216928"}],"container-title":["Journal of Complementary and Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0443\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0443\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:59:26Z","timestamp":1791957566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2024-0443\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,11]]},"published-print":{"date-parts":[[2025,6,3]]}},"alternative-id":["10.1515\/jcim-2024-0443"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2024-0443","relation":{},"ISSN":["1553-3840"],"issn-type":[{"value":"1553-3840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}